$106 | SAVE $19 | Single User
$213 | SAVE $37 | Site License
$319 | SAVE $56 | Enterprise License

Inovio Pharmaceuticals, Inc. - Financial and Strategic SWOT Analysis Review

Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review
[Lowest Price Guaranteed: $106]

Published by Global Data: 05 Jul 2016 | 13317 | In Stock
Related Topics: Business , Cancer , Delivery , Financial , Home , Immunotherapy , Malaria , Pharmaceuticals , Vaccine

Introduction

Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Inovio Pharmaceuticals, Inc. (Inovio) is a biotechnology company which develops active DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on SynCon vaccine and electroporation delivery technologies. Inovio’s clinical programs are focused at treating leukemia, hepatitis C virus, cervical dysplasia, HIV and influenza. Inovio’s collaborators and partners include Merck, ChronTech, the University of Pennsylvania, University of Southampton, National Cancer Institute, NIH, HIV Vaccines Trial Network, U.S. Military HIV Research Program, US Dept. of Homeland Security, University of Manitoba and PATH Malaria Vaccine Initiative. Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals, Inc. Key Recent Developments

May 09, 2016: Inovio Pharmaceuticals Reports 2016 First Quarter Financial Results

Mar 14, 2016: Inovio Pharmaceuticals Reports 2015 Fourth Quarter and Year End Financial Results

Mar 11, 2016: Inovio Pharmaceuticals Appoints DNA Immunotherapy Pioneer David B. Weiner, Ph.D., to its Board of Directors

Jan 19, 2016: Inovio Pharmaceuticals Awarded Grant to Advance Needle-Free Vaccine Delivery Device

Jan 04, 2016: Inovio Pharmaceuticals Adds Dr. Prakash Bhuyan to VGX-3100 Leadership Team for HPV-Related Dysplasia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 5

    Section 1 - About the Company 6

    Inovio Pharmaceuticals, Inc. - Key Facts 6

    Inovio Pharmaceuticals, Inc. - Key Employees 7

    Inovio Pharmaceuticals, Inc. - Key Employee Biographies 8

    Inovio Pharmaceuticals, Inc. - Major Products and Services 9

    Inovio Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data 10

    Inovio Pharmaceuticals, Inc., Pipeline Products by Therapy Area 10

    Inovio Pharmaceuticals, Inc., Pipeline Products by Development Phase 11

    Inovio Pharmaceuticals, Inc. - History 14

    Inovio Pharmaceuticals, Inc. - Company Statement 20

    Inovio Pharmaceuticals, Inc. - Locations And Subsidiaries 23

    Head Office 23

    Other Locations & Subsidiaries 23

    Section 2 – Company Analysis 24

    Inovio Pharmaceuticals, Inc. - Business Description 24

    Inovio Pharmaceuticals, Inc. - Corporate Strategy 25

    Inovio Pharmaceuticals, Inc. - SWOT Analysis 26

    SWOT Analysis - Overview 26

    Inovio Pharmaceuticals, Inc. - Strengths 26

    Strength - Focused Research and Development Initiatives 26

    Strength - Proprietary Technologies 26

    Strength - Strategic Acquisition 26

    Inovio Pharmaceuticals, Inc. - Weaknesses 27

    Weakness - Weak Financial Performance 27

    Weakness - Major Customers and Concentration of Credit Risk 27

    Inovio Pharmaceuticals, Inc. - Opportunities 28

    Opportunity - Market Potential - Cancer Vaccines 28

    Opportunity - Research Grant 28

    Opportunity - Product Pipeline 28

    Opportunity - License agreement with MedImmune 28

    Inovio Pharmaceuticals, Inc. - Threats 29

    Threat - Intense Market Competition 29

    Threat - Tightening of FDA’s Regulatory Oversight 29

    Threat - Dependence on Third Parties 29

    Inovio Pharmaceuticals, Inc. - Key Competitors 30

    Section 3 – Company Financial Ratios 31

    Financial Ratios - Capital Market Ratios 31

    Financial Ratios - Annual Ratios 32

    Performance Chart 33

    Financial Performance 33

    Financial Ratios - Interim Ratios 34

    Financial Ratios - Ratio Charts 35

    Section 4 – Company’s Lifesciences Financial Deals and Alliances 36

    Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 36

    Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 37

    Inovio Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 38

    Inovio Pharmaceuticals, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 39

    Inovio Pharmaceuticals, Inc., Recent Deals Summary 40

    Section 5 – Company’s Recent Developments 41

    May 09, 2016: Inovio Pharmaceuticals Reports 2016 First Quarter Financial Results 41

    Mar 14, 2016: Inovio Pharmaceuticals Reports 2015 Fourth Quarter and Year End Financial Results 42

    Mar 11, 2016: Inovio Pharmaceuticals Appoints DNA Immunotherapy Pioneer David B. Weiner, Ph.D., to its Board of Directors 45

    Jan 19, 2016: Inovio Pharmaceuticals Awarded Grant to Advance Needle-Free Vaccine Delivery Device 46

    Jan 04, 2016: Inovio Pharmaceuticals Adds Dr. Prakash Bhuyan to VGX-3100 Leadership Team for HPV-Related Dysplasia 47

    Nov 09, 2015: Inovio Pharmaceuticals Reports 2015 Third Quarter Results 48

    Sep 21, 2015: Inovio Receives Million Option Grant From DARPA to Advance Ebola Program Development 50

    Aug 19, 2015: NIH scientists and colleagues successfully test MERS vaccine in monkeys and camels 51

    Aug 10, 2015: Inovio Pharmaceuticals Reports 2015 Second Quarter Results 52

    Jul 29, 2015: Inovio Pharmaceuticals' DNA-Based Monoclonal Antibody Protects Animals Against Lethal Challenge 54

    Section 6 – Appendix 55

    Methodology 55

    Ratio Definitions 55

    About GlobalData 59

    Contact Us 59

    Disclaimer 59

List Of Tables
in Inovio Pharmaceuticals, Inc. - Financial and Strategic SWOT Analysis Review

List of Tables

Inovio Pharmaceuticals, Inc., Key Facts 6

Inovio Pharmaceuticals, Inc., Key Employees 7

Inovio Pharmaceuticals, Inc., Key Employee Biographies 8

Inovio Pharmaceuticals, Inc., Major Products and Services 9

Inovio Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area 10

Inovio Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage 11

Inovio Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase 12

Inovio Pharmaceuticals, Inc., History 14

Inovio Pharmaceuticals, Inc., Subsidiaries 23

Inovio Pharmaceuticals, Inc., Key Competitors 30

Inovio Pharmaceuticals, Inc., Ratios based on current share price 31

Inovio Pharmaceuticals, Inc., Annual Ratios 32

Inovio Pharmaceuticals, Inc., Interim Ratios 34

Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 36

Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 37

Inovio Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 38

Inovio Pharmaceuticals, Inc., Medical Equipment, Deals By Type, 2010 to YTD 2016 39

Inovio Pharmaceuticals, Inc., Recent Deals Summary 40

Currency Codes 55

Capital Market Ratios 55

Equity Ratios 56

Profitability Ratios 56

Cost Ratios 57

Liquidity Ratios 57

Leverage Ratios 58

Efficiency Ratios 58

List Of Figures, Charts and Diagrams
in Inovio Pharmaceuticals, Inc. - Financial and Strategic SWOT Analysis Review

List of Figures

Inovio Pharmaceuticals, Inc., Pipeline Products by Therapy Area 10

Inovio Pharmaceuticals, Inc., Pipeline Products by Development Phase 11

Inovio Pharmaceuticals, Inc., Performance Chart (2011 - 2015) 33

Inovio Pharmaceuticals, Inc., Ratio Charts 35

Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 36

Inovio Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 37

Inovio Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 38

Inovio Pharmaceuticals, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 39

Additional Details

Publisher

Global Data

Publisher Information

Reference

13317 | GDPH4623FSA

Number of Pages

59

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Inovio Pharmaceuticals Inc (INO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInovio Pharmaceuticals Inc (Inovio) is a biotechnology company which develops active DNA immu...
10 May 2017 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Inovio Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Inovio Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment...
05 May 2017 by Marketline USD $298 (normally
USD $351)
More Info
SAVE 15% today! Inovio Pharmaceuticals Inc (INO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInovio Pharmaceuticals Inc (Inovio) is a biotechnology company which develops active DNA immu...
20 Mar 2017 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Inovio Pharmaceuticals Inc (INO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInovio Pharmaceuticals Inc (Inovio) is a biotechnology company which develops active DNA immu...
24 Nov 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Inovio Pharmaceuticals, Inc. (INO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInovio Pharmaceuticals, Inc. (Inovio) is a biotechnology company which develops active DNA im...
24 Aug 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Inovio Pharmaceuticals, Inc. (INO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInovio Pharmaceuticals, Inc. (Inovio) is a biotechnology company. It undertakes the developme...
15 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Inovio Pharmaceuticals, Inc. (formerly Inovio Biomedical Corporation) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Project Synopsis:Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and In...
10 Mar 2016 by Marketline USD $298 (normally
USD $351)
More Info
SAVE 15% today! Inovio Pharmaceuticals, Inc. (INO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryInovio Pharmaceuticals, Inc. (Inovio) is a biotechnology company. It undertakes the developme...
04 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review
Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review provides you an in...
15 Dec 2015 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review
Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review provides you an in...
20 Oct 2015 by Global Data USD $106 (normally
USD $125)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Inovio Pharmaceuticals, Inc. (INO) - Financial and Strategic SWOT Analysis Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...